Hugh Paul Oneill serves as EVP, Qual & Ops, Spec Brands at Keenova Therapeutics plc, where they oversee executive responsibilities. Since joining the company, Hugh Paul Oneill has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 25, 2026 involved receiving (via award) 34,528 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | NONE | $0 | Award | 34,528 | $N/A | Discretionary |
| Jan 1, 2026 | NONE | $0 | Option Exercise | 2,055 |
Hugh Paul Oneill currently holds 48,913 shares of Keenova Therapeutics plc (NONE), valued at approximately $0. This represents their equity stake as EVP, Qual & Ops, Spec Brands.
Based on SEC Form 4 filings, Hugh Paul Oneill has been a net neutral trader of NONE stock. They have purchased $0 and sold $0 worth of shares.
Hugh Paul Oneill's most recent insider trade was on Feb 25, 2026, when they sold 34,528 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 1, 2026 | NONE | $0 | Payment | 1,073 | $N/A | Discretionary |
| Jan 1, 2026 | NONE | $0 | Option Exercise | 2,055 | $N/A | Discretionary |